Neurology Clinical Trials Market Demand Analysis & Opportunity 2035
The global neurology clinical trials market is experiencing substantial growth as pharmaceutical and biotechnology companies intensify efforts to develop treatments for neurological disorders. The market was valued at USD 6.05 billion in 2025 and is anticipated to surpass USD 11.04 billion by 2035, expanding at a CAGR of over 6.2% during the forecast period of 2026-2035.
